616 - AMG 714 (Anti-IL-15 MAB) Halts the Progression of Aberrant Intraepithelial Lymphocytes in Refractory Celiac Disease type II (RCD-II): A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study Evaluating AMG 714 in Adult Patients with RCD-II/Pre-EATL
Christophe Cellier(Assistance Publique – Hôpitaux de Paris), Chris J. Mulder(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tom van Gils(University of Gothenburg), Shérine Khater(Hôpital Européen Georges-Pompidou), Peter H. Green(Columbia University), Francisco León(University of California San Diego), Pekka Collin(Tampere University), Wayne Tsuji(University of California San Diego), Sheila E. Crowe(University of California, San Diego), Gerd Bouma(Amsterdam University Medical Centers), Georgia Malamut(Délégation Paris 5), Laura Varela Crespo(Instituto Cajal)
Cited by 10
Related Papers
Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2018|1.7k
European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten‐related disorders
|United European Gastroenterology Journal|2019|987
Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders
|Nutrients|2013|493